Victory Capital Management
ANVS icon

Victory Capital Management’s Annovis Bio ANVS Stock Holding History

Victory Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-192
Closed -$1K – 2538
2020
Q1 		$1K Buy
+192
New +$945 ﹤0.01% 3594

Other funds holding ANVS

WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $706M AUM 48.92% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Victory Capital Management's ANVS Position: Q2 2020 in Review

Victory Capital Management sold out of Annovis Bio (ANVS) in Q2 2020, closing a stake of 192 shares — an estimated $1K sold.

Victory Capital Management first reported a position in ANVS in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 8 funds tracked by Wall St. Rank hold ANVS as of Q2 2020.

  • Victory Capital Management reported no remaining Annovis Bio position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 192 Annovis Bio shares in Q2 2020, an estimated $1K.
  • Victory Capital Management first reported a position in Annovis Bio in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's Annovis Bio position peaked at $1K in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.